Tirzepatide
Metabolism and weight
Requires a professional evaluationWhat is it?
Tirzepatide is a synthetic dual-action peptide that acts as an agonist of the GLP-1 and GIP receptors, two incretin hormones that regulate appetite, metabolism and glucose control.
How does it work biologically?
Tirzepatide binds to and activates GLP-1 and GIP receptors in the body, mimicking the action of natural incretin hormones. This helps regulate appetite, improve insulin sensitivity and slow gastric emptying, supporting better control of weight and blood glucose.
Researched benefits
- Support for body weight reduction.
- Better blood glucose control.
- Improved insulin sensitivity.
- Possible cardiometabolic benefits in clinical studies.
- Favorable effects on metabolic markers.
Important considerations
- It does not replace the diagnosis or treatment of a medical condition.
- Requires individual evaluation in people with a medical history, especially diabetes, gastrointestinal problems or endocrine conditions.
- Dosing and duration should be personalized according to goals and professional supervision.
- May not be suitable in certain cases (e.g. pregnancy, breastfeeding, history of pancreatitis or medullary thyroid cancer).
What to watch for during use
- Lower appetite and a greater feeling of fullness.
- Changes in digestive regularity (nausea, constipation or diarrhea are common at the beginning).
- Gradual decrease in body weight.
- Improvement in blood glucose levels and metabolic markers.
The information presented is educational. It is not a diagnosis, treatment or personalized medical advice. Any protocol must be evaluated by a health professional.